If the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...

Tamil actor Vijay's party, Tamilaga Vettri Kazhagam, has taken charge as Tamil Nadu's new government. Vijay is now the Chief Minister. The ...

As far as India is concerned, the biggest pain point from the US-Iran war in the Gulf region has been the spike in the prices of not only o...

As global markets prioritise quality and regulatory trust, India’s pharma sector is recalibrating beyond its traditional cost advantage.

What we are witnessing in the market these days is similar to scenarios that have played out in the past. There have been many points in th...

From nanobubble tech and agro-exports to e-waste recycling and specialty chemicals, the best Indian MSMEs across 20 categories redefined wh...

Many small drug makers face closure as regulators inspect facilities for quality standards. Thousands of plants may shut down if upgrades a...

New bio-equivalence rules promise safer drugs but could eliminate pharma manufacturers that make medicines affordable. Is there a middle gr...

Small and medium pharmaceutical companies are appealing to the health minister, raising concerns about stringent manufacturing standards im...

Pharma lobby groups are urging for changes to the centralized no-objection certification (NOC) for drug exports due to a significant export...

Data from the CDSCO reveals that numerous MSME pharmaceutical companies in India are producing substandard drugs, failing to meet safety st...

The Central Drugs Standard Control Organisation (CDSCO) has been conducting risk-based inspections of drug manufacturing units as part of a...

"We had met the minister and urged him to help the MSME sector. We want the officials at the regulatory body to become facilitators for the...

The Indian government has issued a notification requiring pharmaceutical companies to adhere to new manufacturing standards in response to ...

The Central Drugs Standard Control Organisation (CDSCO), along with state drug inspectors, has been carrying out inspections as part of a n...

More than 65% of MSME firms have been found to be manufacturing drugs that are not of standard quality (NSQ), during risk-based inspections...

Union minister, Mansukh Mandaviya, has told representatives of the pharmaceutical industry that Schedule M, which requires adherence to goo...